SANDSRX Trademark

Trademark Overview


On Wednesday, June 12, 2024, a trademark application was filed for SANDSRX with the United States Patent and Trademark Office. The USPTO has given the SANDSRX trademark a serial number of 98597600. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, February 6, 2025. This trademark is owned by SandsRX, LLC. The SANDSRX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Specialty pharmacy services
sandsrx

General Information


Serial Number98597600
Word MarkSANDSRX
Filing DateWednesday, June 12, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, February 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSANDS RX
Goods and ServicesSpecialty pharmacy services

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, June 12, 2024
Primary Code035
First Use Anywhere DateThursday, October 26, 2017
First Use In Commerce DateThursday, October 26, 2017

Trademark Owner History


Party NameSandsRX, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWylie, TX 75098

Trademark Events


Event DateEvent Description
Wednesday, June 12, 2024NEW APPLICATION ENTERED
Tuesday, December 31, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025ASSIGNED TO EXAMINER
Monday, January 6, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 6, 2025NON-FINAL ACTION WRITTEN
Monday, January 6, 2025NON-FINAL ACTION E-MAILED
Thursday, February 6, 2025FINAL REFUSAL E-MAILED
Thursday, February 6, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 6, 2025FINAL REFUSAL WRITTEN

Related Keywords


sandsrx services pharmacy specialty